Kintor Pharmaceutical Ltd
HKEX:9939
Kintor Pharmaceutical Ltd
HKEX:9939
Price:
2.73
HKD
-7.46%
Market Closed
Market Cap:
HK$1.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kintor Pharmaceutical Ltd
HKEX:9939
|
CN |
|
Mahindra and Mahindra Financial Services Ltd
BSE:532720
|
IN |
|
N
|
Netum Group Oyj
OMXH:NETUM
|
FI |
|
H
|
Harbour Energy PLC
LSE:HBR
|
UK |
|
A-Zenith Home Furnishings Co Ltd
SSE:603389
|
CN |
|
Asia Tele-Net and Technology Corporation Ltd
HKEX:679
|
HK |
Balance Sheet
Balance Sheet Decomposition
Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Ltd
Balance Sheet Decomposition is not available for
Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Ltd
Balance Sheet
Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Ltd
Currency: CNY
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
138
|
196
|
1 066
|
930
|
865
|
|
| Cash |
138
|
196
|
1 066
|
930
|
865
|
|
| Short-Term Investments |
0
|
0
|
323
|
125
|
10
|
|
| Total Receivables |
0
|
0
|
2
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
351
|
604
|
|
| Other Current Assets |
81
|
25
|
30
|
119
|
29
|
|
| Total Current Assets |
218
|
221
|
1 421
|
1 526
|
1 508
|
|
| PP&E Net |
23
|
113
|
187
|
267
|
285
|
|
| PP&E Gross |
23
|
113
|
187
|
267
|
285
|
|
| Accumulated Depreciation |
6
|
11
|
13
|
21
|
39
|
|
| Intangible Assets |
172
|
179
|
210
|
236
|
236
|
|
| Note Receivable |
0
|
0
|
0
|
39
|
9
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
18
|
|
| Other Long-Term Assets |
10
|
41
|
34
|
0
|
0
|
|
| Total Assets |
424
N/A
|
553
+31%
|
1 851
+235%
|
2 068
+12%
|
2 055
-1%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
1
|
0
|
128
|
102
|
|
| Accrued Liabilities |
6
|
10
|
14
|
22
|
16
|
|
| Short-Term Debt |
0
|
59
|
80
|
0
|
40
|
|
| Current Portion of Long-Term Debt |
45
|
3
|
6
|
9
|
63
|
|
| Other Current Liabilities |
57
|
70
|
69
|
60
|
96
|
|
| Total Current Liabilities |
108
|
143
|
169
|
220
|
318
|
|
| Long-Term Debt |
25
|
2
|
135
|
150
|
183
|
|
| Deferred Income Tax |
39
|
39
|
39
|
39
|
39
|
|
| Other Liabilities |
0
|
0
|
0
|
4
|
20
|
|
| Total Liabilities |
172
N/A
|
184
+7%
|
344
+87%
|
413
+20%
|
560
+36%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
235
|
370
|
927
|
1 704
|
2 609
|
|
| Additional Paid In Capital |
17
|
0
|
2 435
|
3 359
|
4 104
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
252
N/A
|
370
+47%
|
1 508
+308%
|
1 655
+10%
|
1 495
-10%
|
|
| Total Liabilities & Equity |
424
N/A
|
553
+31%
|
1 851
+235%
|
2 068
+12%
|
2 055
-1%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
277
|
277
|
369
|
388
|
447
|
|
Switch to:
Switch to:
See Also
Discover More
